Nuria Garcia Diaz

Postdoctoral Fellow - Institute for Cancer Research
Image of Nuria Garcia Diaz
Norwegian version of this page
Username
Visiting address Ullernchausseen 70 OUS Radiumhospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo
Tags: Cell signalling, Cancer research, Immunology, cancer immunotherapy

Publications

García-Díaz, N; Casar, B; Alonso-Alonso, R; Quevedo, L; [...]; Ortiz-Romero, PL; Piris, MA and Vaqué, JP. PLCγ1/PKCθ downstream signaling controls cutaneous T-cell lymphoma development and progression. Journal of Investigative Dermatology 2021. https://doi.org/10.1016/j.jid.2021.09.024

García-Díaz, N; Piris, MA; Ortiz-Romero, PL and Vaqué, JP. Mycosis fungoides and Sézary syndrome: diagnosis, molecular drivers and therapy. Cancers 2021. https://doi.org/10.3390/cancers13081931

Alonso-Alonso, R; Mondéjar, R; Martínez, N; García-Diaz, N; […]; Scholz, C; Vaqué, JP; Gualberto, A; Piris, MÁ. Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma. Scientific Reports 2020. https://doi.org/10.1038/s41598-020-63434-5

Pérez, C; Mondéjar, R; García-Díaz, N; Cereceda, L; […]; Martínez, N; Vaqué, JP; Ortiz-Romero, PL; Piris, MA. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways. British Journal of Dermatology 2019. https://doi.org/10.1111/bjd.18098

Ruso-Julve, F; Pombero, A; Pilar-Cuéllar, F; García-Díaz, N; […]; Gonzalez-Maeso, J; Martínez, S; Vaqué, JP; Crespo-Facorro, B. Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK molecular effects of antipsychotics. Translational psychiatry 2019. https://doi.org/10.1038/s41398-019-0647-7

Llerena, S*; García-Díaz, N*; Curiel-Olmo, S; Agraz-Doblas, A; […]; Varela, I; Piris, MÁ; Crespo, J; Vaqué, JP.  Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget 2018. *Contributed equally. https://doi.org/10.18632/oncotarget.25766

Pérez, C; González-Rincón, J; Onaindia, A; Almaráz, C; García-Díaz, N; […]; Ortiz-Romero, P; Sánchez-Beato, M; Piris, MÁ; Vaqué, JP. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma. Haematologica 2015.  https://doi.org/10.3324/haematol.2015.132837

Curiel-Olmo, S; García-Castaño, A; Vidal, R; Pisonero, H; Varela, I; León-Castillo, A; Trillo, E; González-Vela, C; García-Díaz, N; […]; Ortiz-Romero, P; Valdizán, E; Piris, MA; Vaqué, JP. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures. Oncotarget 2015. https://doi.org/10.18632/oncotarget.4545

Published Oct. 6, 2021 3:46 PM - Last modified Nov. 5, 2021 2:01 PM